Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

GE Healthcare re-launches online neurological campaign

MIND Online aims to improve understanding of conditions such as Alzheimer's disease

- PMLiVE

Genzyme shocked by FDA’s rejection of Lemtrada

US regulator refuses to approve MS drug on safety grounds

- PMLiVE

Takeda pipeline hit by fasiglifam failure

Diabetes candidate had been set for a 2015 launch

- PMLiVE

Community research

Leveraging ‘controlled’ social web environments to garner healthcare business insights

- PMLiVE

US approval for Novo’s Factor XIII drug Tretten

Becomes first recombinant treatment licensed for a rare clotting disorder

2013: pharma’s year of mobile?

Industry use of the technology stepped up a gear this year

- PMLiVE

CHMP backs Piramal’s Alzheimer’s imaging agent

Neuraceq recommended for approval in Europe

- PMLiVE

Lions Health awards open for entry

Creativity in health festival makes its debut next year

- PMLiVE

PharmApprove appoints Solvay’s Coos De Graaf

He will to lead the agency's new European office

- PMLiVE

The oncology market in Canada

Ten per cent is not enough - simple estimates of the Canadian oncology market overlook a complex picture

EU flag

MEPs agree clinical trial regulation revision

Paves way for EU trial database and simplified online applications for new studies

- PMLiVE

Janssen’s Sirturo wins backing for conditional EU licence

CHMP recommends first-in-class multidrug-resistant tuberculosis treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links